|Mr. Kent J. Thiry||Exec. Chairman||5.41M||8.11M||1956|
|Mr. Javier J. Rodriguez||CEO & Director||2.98M||2.94M||1971|
|Mr. Joel Ackerman||CFO & Treasurer||1.98M||N/A||1965|
|Ms. Kathleen Alyce Waters||Chief Legal Officer||1.19M||N/A||1968|
|Ms. LeAnne M. Zumwalt||Group VP of Purchasing & Public Affairs||683.79k||54.65k||1959|
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2018, it provided dialysis and administrative services in the United States through a network of 2,664 outpatient dialysis centers serving approximately 202,700 patients; and operated 241 outpatient dialysis centers located in 9 countries outside of the United States serving approximately 25,000 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
DaVita Inc.’s ISS Governance QualityScore as of October 4, 2019 is 4. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 2; Compensation: 9.